VeriSee DR is an AI-assisted diagnostic software for diabetic retinopathy (DR) that identifies high-risk DR patients. Its core AI model has been trained from images labeled by retina specialists, and the software has been validated in a pivotal clinical trial against rigorous clinical reference standards. It leverages AI deep learning techniques to produce diagnosis results similar to that of professional ophthalmologists. Besides, it can be run on a device without a network connection.
VeriSee DR is an effective solution that can shorten the screening process, increase the volume of screenings, improve the accuracy and consistency of the results, and improve patient outcomes.